logo

Nektar Therapeutics (NKTR)



Trade NKTR now with
  Date
  Headline
8/9/2018 10:14:19 AM William Blair Is Increasing Nektar Therapeutics (NKTR) FY20 Estimate To -3.06 From -3.82
8/9/2018 10:14:03 AM William Blair Is Raising Nektar Therapeutics (NKTR) FY19 Estimate To -2.69 From -3.38
8/9/2018 10:13:45 AM William Blair Is Raising Nektar Therapeutics (NKTR) FY18 Estimate To 3.22 From 3.09
8/9/2018 10:13:05 AM William Blair Reiterates Nektar Therapeutics (NKTR) At Outperform
8/8/2018 4:12:27 PM Nektar Therapeutics Q2 EPS $5.33 Vs. Loss $0.39 Year Ago
7/30/2018 9:16:29 AM Nektar Therapeutics Says NDA For NKTR-181 Accepted For Review By FDA
5/31/2018 8:17:19 AM Nektar Therapeutics Announces Submission Of NDA To FDA For NKTR-181
5/30/2018 4:06:03 PM Syndax And Nektar Therapeutics Announce Immuno-Oncology Clinical Trial Collaboration
5/10/2018 4:11:46 PM Nektar Therapeutics Q1 Loss Per Share $0.60 Vs Loss $0.42 Last Year
5/8/2018 8:33:56 AM Nektar Therapeutics Begins Phase 1b Clinical Study Of NKTR-358